Kiora Pharmaceuticals, Inc. (KPRX)
USD 3.26
(-6.59%)
USD 3.26
(-6.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 12.05 Thousand | 2.68 Million | 1.65 Million |
| Cost of Revenue | 4.02 Million | 134.02 Thousand | 227.27 Thousand | 200.22 Thousand | 4889.36 | 8.05 Million |
| Gross Profit | -4.02 Million | -134.02 Thousand | -227.27 Thousand | -188.16 Thousand | 2.68 Million | -6.4 Million |
| Operating Expenses | 12.58 Million | 11.72 Million | 10.67 Million | 8.22 Million | 9.79 Million | 12.49 Million |
| Selling, General and Administrative Expenses | 4.66 Million | 8.27 Million | 5.32 Million | 4.65 Million | 4.4 Million | 4.44 Million |
| Research and Development Expenses | 5.93 Million | 3.44 Million | 5.35 Million | 3.56 Million | 5.38 Million | 8.05 Million |
| Other Expenses | - | 582.6 Thousand | 6.26 Million | - | - | - |
| Cost and Expenses | 12.58 Million | 11.72 Million | 10.67 Million | 8.22 Million | 9.79 Million | 12.49 Million |
| Operating Income | -12.58 Million | -12.3 Million | -16.94 Million | -8.18 Million | -7 Million | -10.84 Million |
| Interest Expense | 11.13 Thousand | 8599.00 | 6851.00 | 4186.00 | 325.00 | 1040.00 |
| Income Tax Expense | 90.31 Thousand | -113.01 Thousand | -304.78 Thousand | 12.05 Thousand | 95.39 Thousand | 86.04 Thousand |
| Earnings before Tax | -12.42 Million | -13.69 Million | -16.69 Million | -8.07 Million | -7 Million | -10.72 Million |
| Net Income | -12.51 Million | -13.58 Million | -16.39 Million | -8.09 Million | -7.09 Million | -10.81 Million |
| Earnings Per Share Basic | -24.25 | -18.55 | -68.00 | -70.50 | -89.24 | -182.81 |
| Earnings Per Share Diluted | -24.25 | -18.55 | -68.00 | -70.50 | -89.24 | -182.81 |
| Weighted Average Shares Outstanding | 538 Thousand | 732.3 Thousand | 241.09 Thousand | 114.78 Thousand | 79.52 Thousand | 59.13 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 538 Thousand | 732.3 Thousand | 241.09 Thousand | 114.78 Thousand | 79.52 Thousand | 59.13 Thousand |
| Gross Margin | - | - | - | -15.60 | 1.00 | -3.87 |
| EBIT Margin | - | - | - | -676.34 | -2.53 | -6.47 |
| Profit Margin | - | - | - | -671.03 | -2.64 | -6.54 |
| EBITDA | -12.35 Million | -13.55 Million | -13.72 Million | -6.64 Million | -6.78 Million | -10.68 Million |
| Earnings Before Tax Margin | - | - | - | -679.11 | -2.61 | -6.56 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 20 Thousand | 16 Million | 283.87 Thousand | - | - | - |
| Cost of Revenue | 17.87 Thousand | 16.21 Thousand | 7935.00 | 62.42 Thousand | 42.38 Thousand | 56.69 Thousand |
| Gross Profit | 2123.00 | 15.98 Million | 275.93 Thousand | -62.42 Thousand | -42.38 Thousand | -56.69 Thousand |
| Operating Expenses | 2.42 Million | 2.77 Million | 1.98 Million | 8.62 Million | 2.5 Million | 2.48 Million |
| Selling, General and Administrative Expenses | 1.52 Million | 1.28 Million | 872.61 Thousand | - | 1.41 Million | 1.09 Million |
| Research and Development Expenses | 906.68 Thousand | 1.49 Million | 1.11 Million | - | 1.08 Million | 1.39 Million |
| Other Expenses | -18.86 Thousand | 8066.00 | -65.65 Thousand | 3.89 Million | 105.71 Thousand | -25.88 Thousand |
| Cost and Expenses | 2.44 Million | 2.79 Million | 1.99 Million | 8.69 Million | 2.5 Million | 2.48 Million |
| Operating Income | -2.42 Million | 13.2 Million | -1.99 Million | -8.69 Million | -5.91 Million | -2.63 Million |
| Interest Expense | - | - | 36.99 Thousand | 11.13 Thousand | - | - |
| Income Tax Expense | 3.00 | -2.00 | 90.31 Thousand | 90.31 Thousand | 3.36 Million | 98.53 Thousand |
| Earnings before Tax | -2.22 Million | 13.45 Million | -2.17 Million | -12.42 Million | -5.76 Million | -2.61 Million |
| Net Income | -2.22 Million | 13.45 Million | -2.26 Million | -12.51 Million | -5.76 Million | -2.61 Million |
| Earnings Per Share Basic | -0.53 | 0.52 | -0.29 | - | -0.81 | -0.79 |
| Earnings Per Share Diluted | -0.53 | 0.38 | -0.29 | - | -0.81 | -0.79 |
| Weighted Average Shares Outstanding | 4.17 Million | 25.93 Million | 7.7 Million | 538 Thousand | 7.1 Million | 3.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.17 Million | 35.02 Million | 7.7 Million | 538 Thousand | 7.1 Million | 3.28 Million |
| Gross Margin | 0.11 | 1.00 | 0.97 | - | - | - |
| EBIT Margin | -120.34 | 0.83 | -6.99 | - | - | - |
| Profit Margin | -111.08 | 0.84 | -7.99 | - | - | - |
| EBITDA | -2.4 Million | 13.22 Million | -1.98 Million | - | 928.16 Thousand | -2.32 Million |
| Earnings Before Tax Margin | -121.23 | 0.83 | -7.02 | - | - | - |
N01
AIFS
FAIRCHEMOR
CBQK
MRU
GRDLY